CoreAge Rx vs eMI Aesthetics
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and eMI Aesthetics head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 71 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make eMI Aesthetics a bad call — it's best for readers interested in supported virtual care who can verify the exact medication, full subscription charge and cancellation terms. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | eMI Aesthetics |
|---|---|---|
| Brief Score | 94/100 (A) | 71/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm medication and care total Program advertised from $179/month; semaglutide from $119 and oral semaglutide from $146. Medication figures do not establish a complete billing period, formulation or selected-plan total. Full price detailsCurrent semaglutide formulation and complete quote unknown; medication page lists from $119 and oral from $146 without a complete period/plan; earlier listing: From $179/mo (all doses, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm medication and care total Tirzepatide from $102 and branded Zepbound from $1,399 are separate listings. Confirm the formulation, supplied period and full selected-plan charge. Full price detailsCurrent tirzepatide formulation and complete quote unknown; page lists from $102 and branded Zepbound from $1,399 without establishing the applicable plan; earlier listing: Not disclosed |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises eligible-patient access in all fifty states, subject to clinical and state requirements; confirm the selected treatment |
| Brand-name access | Not confirmed | Named Ozempic and Zepbound choices are advertised; the selected brand, formulation, dispensing pharmacy and full charge need confirmation. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
eMI Aesthetics: Generic program starts at $179/month; medication listings use separate starting figures without a complete selected-plan period or charge.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.